When Congress returns from August recess, lawmakers will face a legislative agenda crowded with funding deadlines and competing priorities. Amid the chaos, one bipartisan bill deserves to move without delay: the ASAP Act, which would create a coverage pathway for new Alzheimer’s detection tests, helping patients get diagnosed earlier and stay independent longer.

Introduced in 2025, the bill cannot afford to sit idle for another year.

Alzheimer’s is a disease of time. Its progression can be meaningfully slowed if it is caught early, and we now have the tools to do just that. Breakthrough diagnostics, including biomarker tests that can detect signs of Alzheimer’s with a simple blood draw, offer a faster, less invasive way to identify the disease.

Diagnosing Alzheimer’s early matters because it buys time to change the course of the disease. Research increasingly shows........

© The Daily Caller